Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature.
Journal: Oncology and therapy
Published: September 13, 2021
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 11, 2019
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 16, 2015
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Journal: The Lancet. Oncology
Published: September 07, 2013
Showing 1-4 of 4
Last Updated: 09/26/2026